Skip to main content
OpenTrials

Clinical trial condition

Scleroderma, Diffuse

Explore clinical trials studying Scleroderma, Diffuse. Study availability and eligibility vary by location and protocol.

220 public trials 51 recruiting studies
Refine in advanced search Browse all conditions

Scleroderma, Diffuse trial results

Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

NCT07085104

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +24 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 14 locations
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Manning Family Children's Hospital of New Orleans New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Recruiting

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

NCT06328777

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +6 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Recruiting

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

NCT07115745

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +29 more
Locations
  • Brigham And Womens Hospital Boston, Massachusetts, United States
  • Duke University Durham, North Carolina, United States
  • Local Institution - 0007 Camperdown, New South Wales, Australia
  • Local Institution - 0008 Brisbane, Queensland, Australia
View all 28 locations
View Trial Details
Recruiting

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

NCT06470048

Conditions
Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, Scleroderma, Diffuse, +3 more
Locations
  • Arizona Arthritis and Rheumatology Research PLLC Mesa, Arizona, United States
  • UCLA Los Angeles, California, United States
  • Hoag Hospital Newport Beach, California, United States
  • Clinical Res Of W Florida Clearwater, Florida, United States
View all 128 locations
View Trial Details
Recruiting

Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

NCT05098704

Conditions
Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +4 more
Locations
  • CH de la Cote Basque - service de rhumatologie Bayonne, France
  • CHU de Bordeaux - service de Médecine Interne et Maladies Infectieuses Bordeaux, France
  • CHU de Bordeaux - service de rhumatologie Bordeaux, France
  • CHU de Brest - service de rhumatologie Brest, France
View Trial Details
Recruiting

Controlling Hyperactive Immunity With Long-lived Lymphocytes

NCT07473154

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +13 more
Locations
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
  • Guy's & St Thomas NHS Foundation Trust London, United Kingdom
  • Royal Free London NHS Foundation Trust London, United Kingdom
View Trial Details
Recruiting

US Zamto-cel Autoimmune Diseases

NCT06708845

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +17 more
Locations
  • Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details

Related conditions